
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT Inc. reported robust same-store net operating income (NOI) growth, with its Senior Housing Operating Portfolio (SHOP) expanding by 25.3% and Integrated Senior Health Campus (ISHC) by 21.7% year-over-year. The company has demonstrated the highest funds from operations (FFO) growth rate within the healthcare REIT sector, bolstered by a favorable cost of capital since late 2024, positioning AHR to pursue strategic investments more aggressively. Additionally, the anticipated compounded annual growth rates (CAGR) of 11.8% and 15.5% for Trilogy and SHOP, respectively, signal strong organic growth potential driven by improved operational efficiencies and external market conditions.
Bears say
American Healthcare REIT Inc. is facing significant challenges that contribute to a negative outlook on its stock due to potential tenant risks and economic headwinds affecting its operations. Despite a reduction in net debt to annualized EBITDA from 5.1x to 3.5x and an improved liquidity position of $997 million, which includes substantial unrestricted cash and credit facility access, concerns remain about the ability of its tenants to maintain operational performance amid changing regulatory conditions. Additionally, if the company fails to meet organic net operating income growth expectations, which could be hindered by acquisition risks and lower Medicaid rates, this performance shortfall could adversely impact overall stock performance.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares